In a significant development within the pharmaceutical industry, Extrovis AG and Dr. Reddy’s Laboratories have joined forces to launch an authorized generic version of CARAC (fluorouracil cream) 0.5% in the U.S. market. This collaboration aims to enhance patient access to proven dermatological treatments for superficial basal cell carcinoma and actinic keratosis—conditions frequently caused by extended exposure to ultraviolet radiation. By introducing this authorized generic,both companies underscore their commitment to delivering cost-effective therapies while expanding treatment choices in a competitive healthcare landscape.
Extrovis AG and Dr. Reddy’s Introduce Authorized Generic CARAC Cream Nationwide
The partnership between Extrovis AG and Dr. Reddy’s Laboratories has resulted in the launch of an authorized generic form of CARAC (fluorouracil cream) at 0.5%, marking a key advancement in making dermatology treatments more accessible across the United States.Combining…
Source link : https://usa-news.biz/2025/08/20/health-medical/extrovis-ag-and-dr-reddys-introduce-authorized-generic-carac-fluorouracil-cream-0-5-to-the-u-s-market/
Author : Miles Cooper
Publish date : 2025-08-21 01:56:00
Copyright for syndicated content belongs to the linked Source.
